United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 27, 2026 · Filed Apr 28, 2026

On Apr 27, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$568.81 for US$5.4M under a trading plan, leaving 40,513 shares. Filed Apr 28, 2026 (Form 4).

Sold
9,500 shares
Price
US$568.81 average (US$565.75 to US$572.22)
Value
US$5.4M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 27, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 27, 2026Common StockSale1,502US$565.7548,511Direct
Apr 27, 2026Common StockSale1,311US$566.5647,200Direct
Apr 27, 2026Common StockSale1,023US$567.6146,177Direct
Apr 27, 2026Common StockSale583US$568.5845,594Direct
Apr 27, 2026Common StockSale1,891US$569.7543,703Direct
Apr 27, 2026Common StockSale1,653US$570.5742,050Direct
Apr 27, 2026Common StockSale1,417US$571.4940,633Direct
Apr 27, 2026Common StockSale120US$572.2240,513Direct

Source

View original at SEC

Related